Preliminary Investigation and Therapeutic Efficacy Determination of a Novel Anti-IL-17A Antibody, Indikizumab.
- DOI
- 10.2147/btt.s477752
- Published
- 2024
- Container
- Biologics : targets & therapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2147/btt.s477752,
title = {Preliminary Investigation and Therapeutic Efficacy Determination of a Novel Anti-IL-17A Antibody, Indikizumab.},
author = {Patra AK and Nayak S and Moharana A and Ojha P and Das SK and Akhtar J and Giri B and Singh S},
year = {2024},
journal = {Biologics : targets \& therapy},
doi = {10.2147/btt.s477752},
url = {https://doi.org/10.2147/btt.s477752}
}RIS
TY - JOUR TI - Preliminary Investigation and Therapeutic Efficacy Determination of a Novel Anti-IL-17A Antibody, Indikizumab. AU - Patra AK AU - Nayak S AU - Moharana A AU - Ojha P AU - Das SK AU - Akhtar J AU - Giri B AU - Singh S PY - 2024 JO - Biologics : targets & therapy DO - 10.2147/btt.s477752 UR - https://doi.org/10.2147/btt.s477752 ER -
APA
AK, P., S, N., A, M., P, O., SK, D., J, A., B, G., & S, S. (2024). Preliminary Investigation and Therapeutic Efficacy Determination of a Novel Anti-IL-17A Antibody, Indikizumab.. Biologics : targets & therapy. https://doi.org/10.2147/btt.s477752
Source records
- pubmed · retrieved 2026-09-26T04:59:13.717Z